Fludarabine
Advanced Mesothelioma
M.D. Anderson Cancer CenterSmall moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
28 Active assets in the Advanced Mesothelioma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
CIS-DIAMMINEDICHLOROPLATINUM II Dr Jean Yannis PERENTES | Phase 2 | BB |
Inno-206 Mayo Clinic | Phase 2 | BB |
Cyclophosphamide M.D. Anderson Cancer Center | Phase 2 | BB |
Sargramostim Memorial Sloan Kettering Cancer Center | Phase 2 | BB |
Alpha-Interferon St. Vincent Medical Center - Los Angeles | Phase 2 | B |
View all 50 →
Same molecule, other indications
Fludarabine is also rated in:
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →